P01
|
P01: Serum S-100B Adds Incremental Value for the Prediction of Symptomatic Intracranial Hemorrhage and Symptomatic Brain Edema After Acute Ischemic Stroke: Data from the Multicentre BIOSIGNAL-Cohort Study
ePoster
Neurovascular disorders
T. Honegger
Präsentierende:r
UniversitätsSpital & Universität ZürichJ. Schweizer UniversitätsSpital & Universität ZürichA. Bicvic UniversitätsSpital & Universität ZürichL. Westphal UniversitätsSpital & Universität ZürichV. Schütz UniversitätsSpital & Universität ZürichC. Inauen UniversitätsSpital & Universität ZürichT. Pokorny UniversitätsSpital & Universität ZürichK. Bracher UniversitätsSpital & Universität ZürichM. Arnold Inselspital - Universitätsspital BernU. Fischer Inselspital - Universitätsspital BernL. Bonati Universitätsspital BaselG. De Marchis Universitätsspital BaselK. Nedeltchev Kantonsspital AarauT. Kahles Kantonsspital AarauC. Cereda Ente Ospedaliero Cantonale, Ospedale Regionale di LuganoG. Kägi Kantonsspital St. GallenJ. Montaner Hospital Universitari Vall d’HebronA. Bustamante Hospital Universitari Germans Trias i PujolE. Palà Vall d’Hebron Institute of Research, Universitat Autònoma de BarcelonaG. Ntaios University of Thessaly LarissaC. Foerch University Hospital Frankfurt am MainA. Luft UniversitätsSpital & Universität ZürichK. Spanaus UniversitätsSpital & Universität ZürichA. von Eckardstein UniversitätsSpital & Universität ZürichM. Arnold UniversitätsSpital & Universität ZürichM. Katan UniversitätsSpital & Universität Zürich
|
P02
|
P02: GENETIC PROXIES FOR PCSK9 INHIBITION ASSOCIATED WITH LOWER LIPOPROTEIN(A): EFFECTS ON CORONARY ARTERY DISEASE AND ISCHEMIC STROKE
ePoster
Neurovascular disorders
G. De Marchis Unispital BaselT. Dittrich
Präsentierende:r
Unispital BaselR. Malik Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-Universität LMU, MunichA. Zietz Unispital BaselL. Kriemler Unispital BaselB. Ference Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, United KingdomM. Dichgans Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-Universität LMU, Munich, GermanyM. Georgakis Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany
|
P03
|
P03: REPERFUSION THERAPIES OF ISOLATED POSTERIOR CEREBRAL ARTERY OCCLUSION: AN ANALYSIS OF THE SWISS STROKE REGISTRY (SSR)
ePoster
Neurovascular disorders
F. Maulucci Stroke Center, Neurology, Neurocenter of Southern SwitzerlandG. Disanto Stroke Center, Neurology, Neurocenter of Southern SwitzerlandG. Bianco Stroke Center, Neurology, Neurocenter of Southern SwitzerlandM. Pileggi Stroke Center, Interventional and Diagnostic Neuroradiology, Neurocenter of Southern SwitzerlandG. Padlina University Hospital Bern, Department of NeurologyU. Fischer University Hospital Bern, Department of NeurologyD. Strambo Lausanne University Hospital, Stroke Center, Neurology ServiceP. Michel Lausanne University Hospital, Stroke Center, Neurology ServiceT. Kahles Kantonsspital Aarau, Department of NeurologyK. Nedeltchev Kantonsspital Aarau, Department of NeurologyU. Fischer University Hospital Basel and University of Basel, Department of Neurology and Stroke CenterL. Bonati University Hospital Basel and University of Basel, Department of Neurology and Stroke CenterG. Kägi Kantonsspital St. Gallen, Department of NeurologyA. Müller Kantonsspital St. Gallen, Department of NeurologyJ. Escribano Paredes Hôpitaux Universitaires de Genève, Department of NeurologyE. Carrera Hôpitaux Universitaires de Genève, Department of NeurologyT. Nyffeler Luzerner Kantonsspital, Center of Neurology and NeurorehabilitationM. Bolognese Luzerner Kantonsspital, Center of Neurology and NeurorehabilitationS. Wegener Universitätsspital Zürich, NeurologyA. Luft Universitätsspital Zürich, NeurologyL. Schelosky Kantonsspital Münsterlingen, Division of NeurologyF. Medlin HFR Fribourg, Stroke Unit, Division of NeurologyB. Rodic Kantonsspital Winterthur, NeurologyA. von Reding Kantonsspital Winterthur, NeurologyN. Peters Hirslanden Hospital, Department of Neurology and Stroke CenterR. Backhaus Hirslanden Hospital, Department of Neurology and Stroke CenterS. Renaud Pourtalès Hospital, Division of NeurologyM. Mono Stadtspital Waid und Triemli, Stroke UnitM. Psychogios University Hospital Basel, Department of NeuroradiologyJ. Kaesmacher University Hospital Bern, Inselspital, NeuroradiologyP. Mordasini University Hospital Bern, Inselspital, NeuroradiologyC. Cereda
Präsentierende:r
Stroke Center, Neurology, Neurocenter of Southern Switzerland
|
P04
|
|
P05
|
|
P06
|
P06: Recurrent stroke in patients with atrial fibrillation – a possible underestimation of stroke etiologies other than cardioembolism?
ePoster
Neurovascular disorders
A. Zietz
Präsentierende:r
Department of Neurology and Stroke Center, University Hospital and University of BaselA. Polymeris Department of Neurology and Stroke Center, University Hospital and University of BaselF. Helfenstein Clinical Trial Unit, Department of Clinical Research, University Hospital BaselL. Hert University and University Hospital of BaselB. Wagner Department of Neurology and Stroke Center, University Hospital and University of BaselG. De Marchis Department of Neurology and Stroke Center, University Hospital and University of BaselH. Gensicke Department of Neurology and Stroke Center, University Hospital and University of BaselL. Bonati Department of Neurology and Stroke Center, University Hospital and University of BaselP. Lyrer Department of Neurology and Stroke Center, University Hospital and University of BaselS. Engelter Department of Neurology and Stroke Center, University Hospital and University of BaselN. Peters Stroke Center Hirslanden, Klinik Hirslanden Zurich and University Hospital of Basel
|
P07
|
|
P08
|
P08: The “Index Vein” is a highly specific sign for migraine aura in the emergency setting
ePoster
Neurovascular disorders
A. Scutelnic
Präsentierende:r
Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieV. Petroulia Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieL. Schraml Inselspital, Bern University Hospital and University of BernS. Jung Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieM. Branca CTU Bern, Institute of Social and Preventive Medicine, University of Bern, Bern, SwitzerlandM. Beyeler Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieU. Fischer Department of Neurology and Stroke Center, University Hospital and University of BaselR. Wiest Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieN. Slavova Universitäts-Kinderspital beider Basel (UKBB)C. Schankin Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
|
P09
|
P09: NEDA-3 status and MAGNIMS score in the first two years predict long-term disability: A single-centre cohort study
ePoster
Neuroinflammation / Neuroinfection
M. Pistor
Präsentierende:r
Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieL. Diem Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieH. Hammer Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieC. Friedli Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieN. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieF. Wagner Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieR. Wiest Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
|
P10
|
P10: Leptomeningeal enhancement under different immunotherapies – a monocentric retrospective cohort study of 215 patients
ePoster
Neuroinflammation / Neuroinfection
C. Friedli
Präsentierende:r
Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieF. Wagner Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieH. Hammer Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieN. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Wiest Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieL. Diem Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
|
P11
|
P11: Cortical Lesion Detection using FLAWS in Multiple Sclerosis
ePoster
Neuroinflammation / Neuroinfection
J. Müller
Präsentierende:r
Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, F. La Rosa Signal Processing Laboratory (LTS5), École Polytechnique Fédérale de LausanneC. Tsagkas Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, R. Rahmanzadeh Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, J. Beaumont Univ Rennes, Inserm, LTSI-UMR1099M. Barakovic Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, P. Lu Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, Ö. Yaldizli Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, M. Weigel Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, L. Kappos Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, J. Kuhle Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, M. Bach Cuadra Signal Processing Laboratory (LTS5), École Polytechnique Fédérale de LausanneG. Gambarota Univ Rennes, Inserm, LTSI-UMR1099C. Granziera Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering,
|
P12
|
P12: Choroid Plexus Volume in Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder
ePoster
Neuroinflammation / Neuroinfection
J. Müller
Präsentierende:r
Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitT. Sinnecker Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitM. Wendebourg Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitR. Schläger Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitJ. Kuhle Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitS. Schädelin Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitP. Benkert Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitT. Derfuss Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitP. Cattin Department of Biomedical Engineering, University of BaselC. Jud Department of Biomedical Engineering, University of BaselF. Spiess Department of Biomedical Engineering, University of BaselM. Amann Medical Imaging Analysis Center AGT. Lincke Section of Neuroradiology, Clinic for Radiology & Nuclear Medicine, University Hospital Basel and University of BaselM. Barakovic Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselA. Cagol Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselC. Tsagkas Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitA. Pröbstel Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitS. Reimann Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitS. Asseyer NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinA. Duchow NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinA. Brandt NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinK. Ruprecht Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu BerlinN. Hadjikhani Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical SchoolS. Fukumoto Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityM. Watanabe Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityK. Masaki Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityT. Matsushita Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityN. Isobe Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityJ. Kira Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityL. Kappos Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitJ. Würfel Medical Imaging Analysis Center AGC. Granziera Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselF. Paul NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinÖ. Yaldizli Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and Universit
|
P13
|
|
P14
|
P14: Vaccination prior to Treatment with Ocrelizumab: A Retrospective Observational Study
ePoster
Neuroinflammation / Neuroinfection
V. Epple
Präsentierende:r
Universitätsspital BaselC. Berger Universitätsspital BaselS. Schaedelin Universitätsspital BaselP. Benkert Universitätsspital BaselL. Kappos Universitätsspital BaselK. Leuzinger Universitätsspital BaselH. Hirsch Universitätsspital BaselJ. Kuhle Universitätsspital BaselM. Mehling Universitätsspital Basel
|
P15
|
P15: Ganglion cell-inner plexiform layer is a marker of brain neuronal loss in multiple sclerosis
ePoster
Neuroinflammation / Neuroinfection
A. Cagol
Präsentierende:r
University of Basel / University Hospital BaselN. Cerda-Fuertes University of Basel / University Hospital BaselM. Stoessel University of Basel / University Hospital BaselM. Barakovic University of Basel / University Hospital BaselR. Rahmanzadeh University of Basel / University Hospital BaselR. Galbusera University of Basel / University Hospital BaselM. D' Souza University of Basel / University Hospital BaselJ. Wuerfel University Hospital Basel and University of Basel / Medical Image Analysis Center Basel AG, Basel, SwitzerlandT. Sprenger DKD Helios Klinik WiesbadenL. Kappos University of Basel / University Hospital BaselY. Naegelin University of Basel / University Hospital BaselJ. Kuhle University of Basel / University Hospital BaselC. Granziera University of Basel / University Hospital BaselA. Papadopoulou University of Basel / University Hospital Basel
|
P16
|
P16: Hypogammaglobulinemia: a possible cause of Multiple Sclerosis-related fatigue?
ePoster
Neuroinflammation / Neuroinfection
L. Diem
Präsentierende:r
Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieM. Evangelopoulos Eginition University Hospital, National and Kapodistrian University of AthensD. Karathanasis Eginition University Hospital, National and Kapodistrian University of AthensV. Natsis Eginition University Hospital, National and Kapodistrian University of AthensN. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieH. Hammer Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieC. Friedli Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
|
P17
|
P17: Ocrelizumab-related Neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS)
ePoster
Neuroinflammation / Neuroinfection
H. Hammer
Präsentierende:r
N. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieM. Pistor Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieL. Diem Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieC. Friedli Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
|
P18
|
P18: Lowering blood cholesterol does not affect inflammation in a murine model of multiple sclerosis
ePoster
Neuroinflammation / Neuroinfection
S. Vigne Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)D. Duc Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)J. Rebeaud Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)B. Peter Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)F. Ruiz Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)Y. Yersin Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)V. Bressoud Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)T. Collet Geneva University Hospitals (HUG)C. Pot
Präsentierende:r
Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
|
P19
|
|
P20
|
|
P21
|
P21: A case of SARS-CoV-2-associated acute disseminated encephalomyelitis
ePoster
Neuroinflammation / Neuroinfection
N. Lohaus
Präsentierende:r
Department of Neurology, University Hospital and University of ZurichI. Reichen
Präsentierende:r
Department of Neurology, University Hospital and University of ZurichR. Reimann Institute of Neuropathology, University Hospital and University of ZurichI. Abela Department of Infectious Diseases and Hospital Epidemiology, University Hospital and University of ZurichI. Jelcic
Präsentierende:r
Department of Neurology, University Hospital and University of Zurich
|
P22
|
|
P23
|
P23: MRZ reaction in MOG antibody-associated autoimmune disease and multiple sclerosis: a single-center experience
ePoster
Neuroinflammation / Neuroinfection
I. Reichen
Präsentierende:r
Department of Neurology, University Hospital and University of ZurichB. Vlad
Präsentierende:r
Department of Neurology, University Hospital and University of ZurichD. Lekaditi Department of Neurology, University Hospital and University of ZurichC. Heuer Department of Neurology, University Hospital and University of ZurichA. Eisele Department of Neurology, University Hospital and University of ZurichM. Ziegler Department of Neurology, University Hospital and University of ZurichM. Reindl Clinical Department of Neurology, Medical University of InnsbruckA. Lutterotti Department of Neurology, University Hospital and University of ZurichA. Regeniter medica Medizinische Laboratorien Dr. F. Kaeppeli AGI. Jelcic
Präsentierende:r
Department of Neurology, University Hospital and University of Zurich
|
P24
|
|
P25
|
P25: Diagnostic and therapeutic challenges in Susac syndrome: Experiences from a case series
ePoster
Neuroinflammation / Neuroinfection
T. Neziraj
Präsentierende:r
Department of Neurology, University Hospital and University of ZurichI. Reichen Department of Neurology, University Hospital and University of ZurichM. Heider Department of Neurology, University Hospital and University of ZurichD. Gramatzki Department of Neurology, University Hospital and University of ZurichA. Pangalu Department of Neuroradiology, University Hospital and University of ZurichI. Jelcic Department of Neurology, University Hospital and University of ZurichM. Weller Department of Neurology, University Hospital and University of ZurichL. Steiner Department of Neurology, University Hospital and University of Zurich
|
P26
|
|
P27
|
|
P28
|
|
P29
|
P29: The Behavioural Dysfunction Questionnaire highly discriminates early-stage behavioural variant frontotemporal dementia from Alzheimer’s disease dementia and major depressive disorder
ePoster
Neurodegenerative diseases / Dementia
A. Semenkova
Präsentierende:r
Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Faculty of Psychology, University of BaselO. Piguet School of Psychology and Brain and Mind Centre, The University of SydneyA. Johnen Clinic for Neurology, Muenster University HospitalS. Bruchmann Clinic for Neurology, Muenster University HospitalM. Schroeter Clinic for Cognitive Neurology, University Hospital Leipzig / Max Planck Institute for Human Cognitive and Brain SciencesC. Linnemann University Psychiatric ClinicM. Mühlhauser University Psychiatric ClinicT. Sauer University Psychiatric ClinicM. Baumgartner memoryclinic-sonnweidS. Anderl-Straub Department of Neurology, University of UlmM. Otto Department of Neurology, University of Ulm / Department of Neurology, University Hospital HalleS. Zimmerer Clinic of Neurology and Neurophysiology, Canton Hospital St. GallenA. Felbecker Clinic of Neurology and Neurophysiology, Canton Hospital St. GallenR. Kressig University Department of Geriatric Medicine FELIX PLATTERM. Berres Faculty of Mathematics and Technology, University of Applied Sciences KoblenzM. Sollberger Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Department of Neurology, University Hospital Basel
|
P30
|
|
P31
|
|
P32
|
|
P33
|
P33: COVID-19 infections and vaccinations in the Swiss Multiple Sclerosis Cohort Study
ePoster
Neurodegenerative diseases / Dementia
V. Epple Neurologic Clinic, University Hospital BaselL. Hauss Neurologic Clinic, University Hospital BaselA. Orleth Neurologic Clinic, University Hospital BaselP. Benkert Clinical Trial Unit, Department of Clinical Research, University Hospital BaselD. Jorganxhi Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University BaselN. Sanderson Department of Biomedicine, University Hospital and University of BaselK. Ivánek Department of Biomedicine, University Hospital and University of BaselL. Kappos Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University BaselL. Achtnichts Department of Neurology, Cantonal Hospital AarauJ. Saxer Department of Neurology, Cantonal Hospital AarauC. Pot Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of LausanneP. Lim Dubois-Ferrière Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of LausanneP. Lalive Department of Neurology, University Hospital of Geneva (HUG)G. Breville Department of Neurology, University Hospital of Geneva (HUG)C. Bridel Department of Neurology, University Hospital of Geneva (HUG)C. Gobbi Department of Neurology, Neurocenter of Southern Switzerland, LuganoC. Zecca Department of Neurology, Neurocenter of Southern Switzerland, LuganoS. Mueller Department of Neurology, Cantonal Hospital St. GallenF. Gruenenfelder Department of Neurology, Cantonal Hospital St. GallenT. Derfuss Neurologic Clinic, University Hospital BaselC. Berger Department of Biomedicine, University Hospital and University of BaselR. Pedotti F. Hoffmann-La Roche Ltd.C. Raposo F. Hoffmann-La Roche Ltd.G. Leibundgut Department of Biomedicine, University Hospital and University of BaselH. Hirsch Department of Biomedicine, University Hospital and University of BaselJ. Kuhle Neurologic Clinic, University Hospital BaselM. Mehling
Präsentierende:r
Neurologic Clinic, University Hospital Basel
|
P34
|
P34: The biological substrate of the Motoric Cognitive Risk syndrome: An Amyloid-/Tau-PET and MR imaging study
ePoster
Neurodegenerative diseases / Dementia
G. Bommarito
Präsentierende:r
Geneva University Hospitals and University of GenevaV. Garibotto Geneva University Hospitals and University of GenevaG. Frisoni Geneva University Hospitals and University of GenevaF. Ribaldi Geneva University Hospitals and University of GenevaS. Stampacchia Geneva University Hospitals and University of GenevaF. Assal Geneva University Hospitals and University of GenevaS. Armand Geneva University Hospitals and University of GenevaG. Allali Geneva University Hospitals and University of GenevaA. Griffa Geneva University Hospitals and University of Geneva
|
P35
|
P35: Post-Approval Safety of Cladribine Tablets With Particular Reference to COVID-19 Outcomes: An Update
ePoster
Neurodegenerative diseases / Dementia
G. Giovannoni Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKJ. Berger Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAT. Leist Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA, USAD. Jack Merck KGaA, Darmstadt, GermanyA. Galazka
Präsentierende:r
Merck KGaA, Darmstadt, GermanyA. Nolting Merck KGaA, Darmstadt, GermanyD. Damian EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany
|
P36
|
P36: Evobrutinib significantly reduces relapses and magnetic resonance imaging outcomes in patients with multiple sclerosis: association with baseline neurofilament light chain levels
ePoster
Neurodegenerative diseases / Dementia
J. Kuhle
Präsentierende:r
Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, and University of Basel, Basel, SwitzerlandL. Kappos Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, and University of Basel, SwitzerlandX. Montalban Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, SpainY. Li EMD Serono Research & Development Institute, Inc., Billerica, MA, USA (an affiliate of Merck KGaA, Darmstadt, Germany)K. Thangavelu EMD Serono Research & Development Institute, Inc., Billerica, MA, USA (an affiliate of Merck KGaA, Darmstadt, Germany)Y. Hyvert Merck KGaA, Darmstadt, GermanyD. Tomic Merck KGaA, Darmstadt, Germany
|
P37
|
P37: Exploratory Analysis of Serum GDF-15 Levels in Patients Receiving Subcutaneous Interferon Beta-1a in the REFLEX Trial
ePoster
Neurodegenerative diseases / Dementia
M. Coray
Präsentierende:r
University Hospital Basel and University of Basel, Department of Biomedicine, Basel, SwitzerlandA. Seitzinger Merck KGaA, Darmstadt, GermanyS. Roy Merck KGaA, Darmstadt, GermanyM. Freedman University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, CanadaF. Barkhof VU University Medical Centre, Department of Radiology, Amsterdam, Netherlands; UCL Institute of Neurology, London, United KingdomG. Comi Università Vita-Salute San Raffaele, Ospedale San Raffaele, Department of Neurology and Institute of Experimental Neurology, Milan, ItalyN. De Stefano University of Siena, Department of Medicine, Surgery and Neuroscience, Siena, ItalyL. Kappos University Hospital Basel and University of Basel, Research Center Clinical Neuroimmunology and Neuroscience Basel, and MS Center, Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research and Biomedical Engineering, Basel,J. Kuhle University Hospital Basel and University of Basel, Research Center Clinical Neuroimmunology and Neuroscience Basel, and MS Center, Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research and Biomedical Engineering, Basel,M. Mehling University Hospital Basel and University of Basel, Research Center Clinical Neuroimmunology and Neuroscience Basel, and MS Center, Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research and Biomedical Engineering, Basel,
|
P38
|
P38: Effect of diet on oral microbiota in Parkinson’s disease
ePoster
Neurodegenerative diseases / Dementia
V. FLEURY
Präsentierende:r
Hôpitaux Universitaire de Genève HUGA. Zekeridou University Clinic of Dental MedicineV. Lazarevic Geneva University HospitalsG. Piumatti Hôpitaux Universitaire de Genève HUGN. Gaïa University of Geneva (UNIGE)E. Berthouzoz University of Geneva (UNIGE)R. Goldstein Hôpitaux Universitaire de Genève HUGC. Giannopoulou University Clinic of Dental MedicineA. Mombelli University Clinic of Dental MedicineJ. Schrenzel Geneva University Hospitals (HUG)L. Genton Geneva University Hospitals (HUG)P. Burkhard Geneva University Hospitals (HUG)
|
P39
|
|
P40
|
P40: Different awareness domains contributes to explain emotional and behavioral disorders in mild Alzheimer’s disease
ePoster
Neurodegenerative diseases / Dementia
l. sacco
Präsentierende:r
Ente Ospedaliero CantonaleC. Defanti Center of Excellence for the treatment of Alzheimer's disease, European Biomedical Research FoundationN. Parietti Neurocenter of southern Switzerland, Department of Neurology, Memory Clinic, Neuropychology and Behavioral Neurology Research UnitS. Rossi Neurocenter of southern Switzerland, Department of Neurology, Memory Clinic, Neuropychology and Behavioral Neurology Research UnitP. Tiraboschi IRCCS Carlo BestaG. Riccitelli Neurocenter of southern Switzerland, Department of Neurology, Memory Clinic, Neuropychology and Behavioral Neurology Research Unit
|
P41
|
|
P42
|
|
P43
|
|
P44
|
P44: Patients with amyotrophic lateral sclerosis without behavioural disorders are not impaired in recognising negative facial emotions
ePoster
Neuromuscular disorders
C. Gerber Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Faculty of Psychology, University of Basel D. Lulé Department of Neurology, Ulm University Medical CenterN. Braun Kantonsspital St. Gallen Muskelzentrum / ALS ClinicK. Schweikert ALS Sprechstunde, REHAB Basel / Department of Neurology, University Hospital Basel M. Weber Kantonsspital St. Gallen Muskelzentrum / ALS ClinicR. Kressig University Department of Geriatric Medicine FELIX PLATTERO. Piguet School of Psychology and Brain and Mind Centre, The University of SydneyM. Sollberger
Präsentierende:r
Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Department of Neurology, University Hospital Basel
|
P45
|
|
P46
|
|
P47
|
|
P48
|
P48: Botulinum toxin restores sleep homeostasis in cervical dystonia
ePoster
Movement disorders
S. Caverzasio
Präsentierende:r
Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoN. Amato Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoG. Chiaro Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoC. Staedler Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoA. Kaelin-Lang Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoS. Galati Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano
|
P49
|
|
P50
|
|
P51
|
P51: The Basel Version of the Awareness of Social Inference Test – Theory of Mind (BASIT-ToM): Preliminary Validation Analyses in Healthy Subjects
ePoster
Others
M. Jarsch Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Faculty of Psychology, University of Basel O. Piguet School of Psychology and Brain and Mind Centre, The University of SydneyC. Sluka University of Basel and University Hospital BaselN. Huber Memory Clinic, University Department of Geriatric Medicine FELIX PLATTERR. Kressig University Department of Geriatric Medicine FELIX PLATTERA. Monsch Memory Clinic, University Department of Geriatric Medicine FELIX PLATTERM. Berres Faculty of Mathematics and Technology, University of Applied Science KoblenzM. Sollberger
Präsentierende:r
Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Department of Neurology, University Hospital Basel
|
P52
|
|
P53
|
|
P54
|
|
P55
|
|
P56
|
P56: Anosognosia for memory dysfunction as a key determinant of cognitive and psychiatric symptoms in long COVID
ePoster
Others
P. Voruz
Präsentierende:r
Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland G. Allali Hôpitaux Universitaire de Genève HUGL. Benzakour Hôpitaux Universitaire de Genève HUGA. Nuber-Champier Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland M. Thomasson Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland I. Jacot de Alcantara Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland A. Cionca Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland P. Lalive d'Epinay Hôpitaux Universitaire de Genève HUGK. Lövblad Hôpitaux Universitaire de Genève HUGM. Nehme Hôpitaux Universitaire de Genève HUGO. Braillard Hôpitaux Universitaire de Genève HUGM. Coen Hôpitaux Universitaire de Genève HUGJ. Serratrice Hôpitaux Universitaire de Genève HUGJ. Reny Hôpitaux Universitaire de Genève HUGJ. Pugin Hôpitaux Universitaire de Genève HUGI. Guessous Hôpitaux Universitaire de Genève HUGB. Landis Hôpitaux Universitaire de Genève HUGF. Assal Hôpitaux Universitaire de Genève HUGJ. Péron Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland
|
P57
|
|
P58
|
|
P59
|
|
P60
|
|
P61
|
|